Engelhardt Eva Anette: insider trades.
Engelhardt Eva Anette reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- ENGELHARDT EVA ANETTE
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | Officer · EVP, President, CDG | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-06 | Bio-Rad Laboratories, Inc. | M | 1,152 | $0 | 2,313 | Form 4 |
| 2026-09-06 | Bio-Rad Laboratories, Inc. | F | 485 | $386.11 | 1,828 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | M | 1,027 | $0 | 1,530 | Form 4 |
| 2026-09-05 | Bio-Rad Laboratories, Inc. | F | 369 | $386.11 | 1,161 | Form 4 |
| 2026-07-25 | Bio-Rad Laboratories, Inc. | F | 89 | $314.46 | 503 | Form 4 |
| 2026-07-25 | Bio-Rad Laboratories, Inc. | M | 246 | $0 | 592 | Form 4 |
Questions
What stock did Engelhardt Eva Anette buy or sell?
Engelhardt Eva Anette reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Engelhardt Eva Anette the same person as other filers with this name?
This page covers SEC CIK 2024911 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/engelhardt-eva-anette-2024911.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.